Here we describe new fluorescent probes based on fluorescein and rhodamine that provide reversible, real-time insight into cellular redox status. The new probes incorporate bio-imaging relevant fluorophores derived from fluorescein and rhodamine linked with stable nitroxide radicals such that they cannot be cleaved, either spontaneously or enzymatically by cellular processes. Overall fluorescence emission is determined by reversible reduction and oxidation, hence the steady state emission intensity reflects the balance between redox potentials of critical redox couples within the cell. The permanent positive charge on the rhodamine-based probes leads to their rapid localisation within mitochondria in cells. Reduction and oxidation also leads to marked changes in the fluorophore lifetime, enabling monitoring by fluorescence lifetime imaging microscopy. Finally, we demonstrate that administration of a methyl ester version of the rhodamine-based probe can be used at concentrations as low as 5 nM to generate a readily detected response to redox stress within cells as analysed by flow cytometry.
Introduction
Nitroxide free radicals, or more correctly aminoxyls, have been known for more than 170 years and can act as antioxidants, either directly or after conversion to a hydroxylamine. The first reported example of a nitroxide free radical was that of Frémy's salt, which was synthesised in 1845 [1] . Although it is likely that there were nitroxides generated in Piloty's reactions of potassium cyanide with isobutyramidine in the early 1900s [2] , it would take a further 50 years and the development of magnetic resonance spectroscopy before the work of Lebedev [3] and later Henderson [4] sparked a remarkable period where nitroxides, spin labels and spin trapping generated insight into materials science, structural biology and the understanding of reactive intermediates. As nitroxides are stable towards many solvents and reagents as well as the atmosphere, while possessing an unpaired spin that rapidly scavenges reactive free radicals, they were quickly exploited as potent antioxidants. Even today, modern "plastics" contain significant levels of hindered amine stabilisers that are precursors to nitroxides [5] , thereby retarding oxidation and extending application lifetimes. In free radical biology it was rapidly determined that nitroxides interact with superoxide in vitro [6] acting as superoxide dismutase mimetics [7] , as they reproduce some of the impact of those enzymes that degrade superoxide. However, for kinetic reasons, the antioxidant effects reported for nitroxides in vivo most likely follow their rapid metabolic conversion to hydroxylamines [8] . The remarkable chemistry of nitroxides arises from them being persistent entities existing in between less stable one-electron reduction and one-electron oxidation products, each of which can be accessed at biologically relevant redox potentials (Fig. 1A.) .
Subtleties in the chemical structure, including the ring size, type and substitution influence these redox potentials [9] . However, it is important to note that, despite being known as antioxidants, most nitroxides exposed to living systems, are reduced to the non-radical hydroxylamine [10] . This demonstrates that, within a living system, nitroxides are treated as oxidants, requiring cells to use some of their reductive capacity to reduce the nitroxide to the non-radical species. Whilst this rapid reduction leads to signal loss and limits electron paramagnetic resonance (EPR) imaging, it also presents a unique means to assess the redox state of redox couples within living systems that interact with nitroxides and their reduced and/or oxidised products. More rapid reduction of the nitroxide represents functional reducing capacity, whereas slower reduction reflects compromised reducing capacity, which may indicate disease and consequent cellular dysfunction. Complicating the situation is oxygen, which can re-oxidise the hydroxylamine back to the nitroxide. Thus, the steady-state amount of nitroxide present in a living system depends on a range of factors including: the ease of oxidation of the hydroxylamine; the concentration and nature of oxidising species; the speed of the reduction of the nitroxide; the localisation of the nitroxide within the cell; the polarity/ lipophilicity and charge of the molecule; and also the ease with which nitroxides can interact with reductive enzymes and other biologically relevant reducing agents such as ascorbate, ubiquinol and, indirectly, glutathione. Importantly this reversibility of nitroxide oxidation and reduction imparts an advantage to the use of nitroxides as biological probes. A probe that establishes a paramagnetic/diamagnetic equilibrium in response to local conditions within a biological system will respond to, in real-time and reversibly, the overall redox status of cognate redox couples within the cellular system being investigated and will respond in real time to any changes to these couples, such as those in response to pathology, drugs and environmental stresses (Fig. 1B. ). However it is important to note that these responses will be dominated by the entirety of the biological milieu and that there is not one "redox couple" or "redox state" reported on by these probes.
In an earlier attempt to exploit these properties we designed [11] a structurally efficient fluorescein-based, dual mode fluorescent probe ( Fig. 1C .: 2a. R 2 = -CH 3 ) designed to respond to aspects of the redox status of the cell. The combination of a fluorophore in close proximity to the spin of a nitroxide leads to substantial quenching of emission of the fluorophore. We coined the term "pro-fluorescence" [12, 13] to describe this effect, by analogy with the "pro-drug" terminology widely used in medicinal chemistry and which reflects how metabolism and chemical conversion reveals the active fluorophore. The probe 2a Fig. 1 . A. Nitroxides exist at an oxidation state between more oxidised (oxoammoninium ions) and more reduced (hydroxylamine) forms. B. When exposed to living systems nitroxides are reduced to non-radical hydroxylamines. This transformation is reversed in the presence of oxygen and other oxidising species including many reactive oxygen species (ROS). The steady state level of nitroxides can be monitored by EPR, or by fluorescence when fluorophores are incorporated within the structure. C. Carboxyisoindoline nitroxides (1) serve as precursors for fluorescein-based pro-fluorescent nitroxides (2) and rhodamine-based nitroxides (5 and 8).
contained a widely exploited fluorophore (fluorescein) suitable for the lasers used in confocal microscopy and flow cytometry. It also had a built-in nitroxide that put the spin in close proximity to the fluorophore for maximum quenching [14] and, most importantly, did not allow enzymatic or spontaneous fluorophore-nitroxide cleavage. However, biological systems, even those compromised by disease, still maintain some degree of redox homeostasis and thus should still able to rapidly reduce the nitroxide moiety present in 2a and switch on fluorescence. To achieve significant differentiation between normal and stressed cells, it was necessary to interfere with redox homeostasis by adding 2-deoxyglucose to block glycolysis and thus shift the cells to more oxidising conditions. We then added rotenone to block mitochondrial complex I and generate reactive oxygen species (ROS). The subsequent changes in cellular redox balance could be followed by flow cytometry using our pro-fluorescent nitroxide (PFN) probe and allowed us to demonstrate changes in probes status reflecting redox couple changes within the cell.
Recently we [15] and others [16] have introduced further structural changes to antioxidant nitroxides that have been used to intervene in enzyme and neutrophil dysfunction. These changes decrease the rate of reduction and prolong nitroxide lifetime. Specifically, replacement of the four methyl groups that cradle the nitroxide spin with larger, more electron-rich ethyl groups, extends the nitroxide lifetime both in vitro [15] and in vivo [16] . Building on these ideas, we subsequently developed tetraethylisoindoline nitroxides substituted with carboxy groups [17] and used these to make a fluorescein-based PFN (2b, R 2 = -CH 2 CH 3 ). While the four ethyl groups in the PFN 2b convey some advantages over first generation PFN probes, fluoresceins have poor emissivity at low pH and are susceptible to photobleaching. Consequently, an extension to this approach generated a rhodamine analogue (5), which could be synthesised from 2b. Rhodamines are less pH sensitive and less prone to photobleaching. Most importantly, the positive charge on rhodamines leads to their accumulation in mitochondria and this characteristic was further enhanced through the esterification of 5 to give 8.
The mitochondrion is an important organelle, with a critical influence over the redox status of the cell. Mitochondria are a major focus for drug development, reflecting their key role in a range of pathologies [18] [19] [20] [21] [22] , as well as being a major site of cellular radical production. A number of nitroxides [23] [24] [25] [26] have been described that are targeted to mitochondria. These have mostly involved triphenylphosphonium ions following the early work by Murphy and co-workers [27] suggesting the use of charged lipophilic catiion side-chains to induce enhanced delivery of antioxidants into mitochondria. A notable alternative to this approach has been the elegant methodology of Kagan and Wipf et al. [28, 29] , who used peptides based on the natural product hemigramicidin to induce mitochondrial uptake. To our knowledge, all of the mitochondria-targetted compounds described involve rapidly reduced tetramethyl nitroxides and/or cleavable linkers between the nitroxide and the side-chain.
Accumulation in response to the mitochondrial and plasma membrane potential can lead to the many hundred-fold enhanced concentrations of nitroxides in the mitochondrial matrix [30] . However it is important to note that, no matter the equilibrium position, these probes rapidly shuttle in and out of the mitochondria, with these organelles representing only a proportion of a cell's total volume. Consequently, even mitochondrially-targeted nitroxides are also present in the rest of the cell, where they are subject to differing biochemical processes. One of the challenges for all mitochondrial probes therefore, is managing the response arising from non-mitochondrially localized probes exposed to significantly different chemical environments from those of the mitochondria. To address this, an ideal mitochondria-targeted PFN probe should be less responsive in the cytosol and extracellular environment, predominantly switching on inside the mitochondria. The slower reduction of the tetra-ethyl, rhodamine-based nitroxide 5 represents one means to achieve this goal.
Herein we extend our earlier work and report the synthesis and properties of carboxyisoindoline nitroxides and their conversion into redox-responsive fluorescein and rhodamine pro-fluorescent probes that respond in real-time and reversibly to changes in the redox status of certain redox couples in living systems. The presence of bulky ethyl groups limits fluorescence switch-on to highly reducing environments and, in combination with the positively charged rhodamine structure, effectively confines the fluorescence response to within mitochondria. This makes the probes suitable for imaging redox changes within cells for extended periods of time and has implications for developing our understanding of mitochondrial metabolism and pathology.
Materials and methods

General methods
Reagents and probes
MitoTracker Green, LysoTracker Blue, MitoSox and Hoechst 33258 were supplied by Molecular Probes. All solvents used were Analytical Reagent (AR) grade and all other chemical reagents were of Laboratory Reagent (LR) quality or better and were used as supplied by the manufacturer.
Preparation of compounds
Analytical thin-layer chromatography (TLC) was performed using Merck Silica Gel 60 F 254 TLC plates. Preparative column chromatography was performed using Merck Silica Gel 60 (mesh 230-400). Mass spectra were recorded using a Bruker Apex 3 Fourier transform ion cyclotron resonance mass spectrometer with a 4.7 T magnet. Analytical HPLC was performed on a Hewlett Packard 1100 series HPLC, using an Agilent prep-C18 scalar column (10 µm, 4.6 × 150 mm) at a flow rate of 1 mL/min. Fluorescence spectra were obtained using either a Varian Cary Eclipse fluorescence spectrophotometer (Agilent Technologies, USA) equipped with a standard multi-cell Peltier thermostatted sample holder, or a Shimadzu RF-5301PC fluorescence spectrophotometer (Shimadzu Scientific Instruments Inc., Japan) equipped with a magnetic stirrer.
Synthesis of tetramethyl and tetraethyl nitroxides (1a-d)
These nitroxides were synthesised following procedures described by Fairfull-Smith et al. [17] and references therein.
Synthesis of tetramethylfluorescein nitroxide (2a)
This probe was synthesised following the method described by Morrow et al. [11] 
Synthesis of tetraethylfluorescein nitroxide (2b)
5,6-Dicarboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (1b) (150 mg, 0.45 mmol) was dissolved in acetic anhydride (Ac 2 O, 3 mL) and heated for 1 h at 95°C. The solution was returned to room temperature and the acetic anhydride was removed by distillation under reduced pressure to give an orange solid. This solid was taken up in methane sulfonic acid (MeSO 3 H, 1.5 mL) and resorcinol (99 mg, 0.90 mmol, 2 equiv) was added. The mixture was heated at 85°C for 16 h before being poured onto ice. NaOH (5 M) was carefully added to dissolve the precipitate and the solution was stirred for 15 min. The solution was cooled to 0°C and acidified with HCl (conc. 
Synthesis of tetramethylfluorescein triflate nitroxide (4a)
To a solution of the fluorescein nitroxide (2a, 50 mg, 0.112 mmole) in DCM (0.15 mL), triethylamine (Et 3 N, 34 μL, 2.44 mmole, 2.2 equiv.) was added and stirred at 0°C for 5 min whereupon trifluoromethanesulfonyl chloride was added (42 mg, 26 μL, 0.772 mmol, 2 equiv.) The mixture was allowed to return to room temperature and stirred over a period of 6 h. A volume of DCM (~20 mL) was added to the reaction mixture, and the organic phase was washed with 2 M HCl (2 × 40 mL) and brine (20 mL). The DCM extract was dried over Na 2 SO 4 and the solvent was evaporated under reduced pressure. The crude material was purified by flash chromatography (SiO 2 , 98% DCM/ 2% acetone) to give the triflate derivative as a white solid (67.4 mg, 85%). +ESI HRMS found (M + H) + 709.05055 (0.8 ppm from calc.
mass of C 28 H 21 NO 10 F 6 S 2 .
Synthesis of tetraethylfluorescein triflate nitroxide (4b)
Trifluoromethanesulfonyl chloride (152 mg, 96 μL, 0.90 mmol, 4 equiv) was added dropwise to a solution of tetraethyl fluorescein nitroxide 2b (113 mg, 0.23 mmol) and Et 3 N (138 μL, 0.99 mmol, 4.4 equiv) in 2 mL of dichloromethane (DCM) at 0°C. The mixture was allowed to return to room temperature over a period of 1 h. A volume of DCM (4 0 mL) was added to the reaction mixture, and the organic phase was washed with 2 M HCl (2 × 40 mL) and brine (40 mL). The DCM extract was dried over Na 2 SO 4 and the solvent was evaporated under reduced pressure. The crude material was purified by flash chromatography (SiO 2 , DCM) to give the triflate derivative as a pale yellow solid (147 mg, 85%). Crystals suitable for elemental analysis could be obtained by recrystallisation from hexane (76 mg, 52% recovery 
Synthesis of tetraethylrhodamine nitroxide (5b)
A Schlenk tube was flame dried under high vacuum and returned to room temperature under a flow of argon. The reaction vessel was charged with Pd(OAc) 2 (1.8 mg, 0.008 mmol, 10 mol% Pd), ( ± )-BINAP (7.3 mg, 0.012 mmol, 15 mol%) and toluene (2 mL). This mixture was stirred for 10 min until a peach-colored suspension had formed. Tetraethylfluorescein triflate nitroxide (4b) (60 mg, 0.08 mmol), pyrrolidine (16 μL, 0.18 mmol, 2.4 equiv) and Cs 2 CO 3 (72 mg, 0.22 mmol, 2.8 equiv) were then added to the mixture and the vessel was flushed with argon for 10 min. The temperature was raised to 85°C, the vessel was sealed and the reaction mixture was stirred at this temperature for 24 h. A volume of Et 2 O (~40 mL) was added to the reaction mixture and the organic phase was washed the HCl (2 M, 3 × 40 mL). The acidic aqueous phase was cooled to 0°C and made basic by the dropwise addition of NaOH (10 M). The product was extracted into Et 2 O (3 × 40 mL), the organic phases were combined and subsequently washed with brine and dried over Na 2 SO 4 . The solvent was removed under reduced pressure and the crude solid was purified by flash column chromatography (solvent gradient from CHCl 3 + 0.5% v/v Et 3 N to 90% CHCl 3 /10% MeOH + 0.5% v/v Et 3 N). The purified fraction was isolated as a purple solid (20.1 mg, 42% 
Synthesis of tetraethylrhodamine nitroxide methyl ester (8b)
Acetyl chloride (200 μL, 2.8 mmol) was added dropwise to a suspension of tetraethylrhodamine nitroxide 5b (11.2 mg, 1.85 mmol) in anhydrous methanol (1.5 mL). The resulting solution was heated at 50°C for 2 days. The reaction mixture was diluted with water and extracted with EtOAc and CHCl 3 . The combined organic layers were dried (anhydrous MgSO 4 ) and concentrated in vacuo to give 8b as a sticky pink solid (0.063 g, 55%).
Synthesis of methyl adduct of tetraethylrhodamine nitroxide (10b)
Hydrogen (12. 5 μL, 0.15 mmol, 3 equiv) were dissolved in anhydrous dioxane (0.1 mL) and heated under argon at 100°C for 16 h. The reaction was cooled HCl (2 M, 15 mL) was added and the acidic phase was washed with Et 2 O (2 × 20 mL). The aqueous phase was removed under reduced pressure and the residue taken up in EtOH (~10 mL). Et 2 O was added to help precipitate inorganic salts and the solution filtered and then evaporated to dryness under vacuum. The crude product was partially purified by flash column chromatography (80% EtOAc / 20% EtOH with~1% Et 3 N added to limit streaking) to give purple solid (7 mg, < 25%) which melted with decompositon > 300°C. +ESI HRMS gave a peak (M) + 551.27916 (1.4 ppm from calc. mass of C 34 H 37 N 3 O 4 ). However there were other peaks present and HPLC gave a broadened peak reflecting limited purity.
Cell culture methods
Cell lines were maintained in exponential growth as monolayers in Dulbecco's modified Eagle's medium (DMEM) or Advanced DMEM. For neonatal foreskin fibroblasts immortalised with human telomerase reverse transcriptase (NFF hTERT), DMEM was supplemented with 12% foetal calf serum (FCS), and 1% penicillin-streptomycin antibiotics; for DLD-1 colorectal adenocarcinoma cells, 4% FCS, 1% glutamine and 1% antibiotic-antimycotic were used. The cells were incubated under standard culturing conditions at 37°C, with 5% (v/v) CO 2 under humidified conditions. For imaging experiments, phenol red containing DMEM was exchanged for phenol-red free DMEM. NFF hTERT were also regularly tested for mycoplasma contamination using MycoAlert (Lonza) and Hoechst 33258 staining.
Flow cytometry
NFF hTERT were cultured as detailed above to sub-confluent (approximately 2 × 10 5 cells per mL) and confluent (approximately 6 × 10 5 cells per mL) levels over a period of 48 h in 6-well plates. Cells were treated with nitroxide probe (5b, 6b: 1 μM. 8b, 9b: 5 nM) or MitoSOX™ in complete media at 37°C, 5% CO 2 for 45 min, after which they were washed with PBS and then incubated with various concentrations of rotenone or antimycin for 15 min (F s ). All control wells (F c ) were treated with media containing vehicle (DMSO). Cells were then detached using trypsin/versene and pelleted via centrifugation at
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1200 rpm for 4 min. The supernatant was removed and the cells were resuspended in 1 mL PBS in preparation for flow cytometry using a Becton-Dickinson LSRFortessa Flow Cytometer. All samples were kept in the dark to avoid photobleaching prior to measurement. Between each run, the system was rinsed and cleaned with bleach (70% v/v) to avoid cross-contamination. Probes 5b, 6b, 8b and 9b were excited with a 561 nm laser and emission was detected using a 582/15 nm filter set. MitoSox™ was excited with a 488 nm laser and emission was detected using a 582/15 nm filter set. Data were collected from a total of 10000 cells per sample. Sample data were gated on acquisition to exclude oversized/doublets and necrotic material. Mean fluorescence intensity values from control (F c ) and treated (F s ) samples were used to calculate the percentage change in fluorescence intensity (% Δ F) after treatment using the following equation:
Fluorescence microscopy
Fluorescence imaging studies to determine subcellular localisation of nitroxide probes were performed using a Deltavision wide-field microscope (Applied Precision) with an enclosed environmental chamber (37°C, 5% CO 2 ). Cells were plated into 8-well chamber slides (Ibidi) at a density of 1. 
Fluorescence spectroscopy
Fluorescence measurements were conducted on a Varian Cary Eclipse fluorescence spectrophotometer fitted with a microplate reader accessory or a Shimadzu RF-5301PC spectrofluorophotometer (Shimadzu Scientific Instruments Inc., Japan) equipped with a magnetic stirrer. Fluorescein nitroxide 2 was excited at 490 nm, and the emission was detected at the peak around 525 nm or over the range 495-600 nm. Reduction reactions with ascorbate and hydrazine were conducted in 0.01 M phosphate-buffered saline, pH 7.4 (PBS). Nitroxide probes 2, 5 or 8b, or the methoxyamine derivatives, were added to samples at a final concentration of 1 μM, or less, from a 10 mM stock solution prepared in DMSO or EtOH/PBS. Stock solutions of the probes were stored in a − 23°C freezer until use. As ascorbate in solution can be unstable, reduction experiments were performed using a fresh 0.5 M stock solution of ascorbate prepared for each experiment with appropriate dilutions made to achieve a final ascorbate concentration of 100 μM.
Fluorescence lifetime imaging microscopy (FLIM)
Fluorescence lifetime images were collected on a Leica TCS SP5 MP FLIM system containing a tunable Mai Tai Deep See multi-photon laser with a repetition rate of 80 MHz (Spectra-Physics) connected to a Leica DMI6000B-CS inverted microscope. Samples were illuminated with 820 nm laser and emitted light was collected in the de-scanned internal FLIM detectors over the 550 -650 nm using a HCPLAPO 63 × waterimmersion (NA = 1.20) objective lens. The data was collected with the aid of the B&H SPCM software and the fluorescence lifetimes were determined using time correlated single photon counting (TCSPC) and analysed with SPC Image software (version 3.1.0.0). The instrument response function was derived from the decay curve of urea. 512 × 512 pixel images were collected and 3 × binning applied for analysis to ensure that at least 1 × 10 4 photons per pixel were analysed. Each sample was scanned for 120 s. Analysis of fluorescence lifetimes in cells required individually fitted mono or bi-exponential curves to obtain average χ 2 values closest to 1.
Mitochondrial preparations and incubations
Bovine heart mitochondrial membranes were prepared as described [31] and stored at − 80°C and incubated at 0.2 mg protein/mL in KCl buffer. Mitochondria were prepared from the hearts of female Wistar rats of 10-12 weeks of age (Charles River, UK). Animals were killed by stunning followed by cervical dislocation, and the liver and heart were removed to ice-cold buffer. Rat heart mitochondria were isolated by homogenisation and differential centrifugation at 4°C in buffer containing 250 mM sucrose, 5 mM Tris-Cl, and 1 mM EGTA (pH 7.4) supplemented with 0.1% (w/v) fatty acid-free bovine serum albumin. Protein content of the mitochondrial preparations was determined using the biuret assay with bovine serum albumin as a standard. Mitochondrial incubations were performed in KCl buffer [120 mM KCl, 10 mM HEPES, 1 mM EGTA (pH 7.2)], unless stated otherwise. PFN probes 2b and 8b were dissolved in EtOH (1 mg/mL) and diluted in PBS to give final concentrations of 0.2-2.0 μM in a total volume of 3 mL of PBS in a 1 × 1 cm 2 quartz fluorimeter cell loosely capped with a Teflon lid and stirred with a Teflon coated micro stirrer bar at 400 rpm to keep the membranes or mitochondria in suspension.
Results
Antioxidant action and bio-availability of tetra-methyl vs tetra-ethyl carboxy isoindoline nitroxides
The original pro-fluorescent fluorescein nitroxide (2a) was derived [11] from the dicarboxytetramethylisoindoline nitroxide 1d. The carboxy nitroxide CTMIO (1a) is a tetra-methyl nitroxide and such species, along with related antioxidants, have efficacy in cells and in vivo [32] [33] [34] [35] [36] [37] [38] [39] . Recent attention has focused on more structurally hindered tetra-ethyl analogues [16] , with the hope of enhancing activity by limiting bio-reduction [8] . However, the replacement of the methyl groups in CTMIO (1a) with ethyl groups (to give 1c), gives a compound that is insoluble in water. Introduction of an extra carboxyl group [40] gave the more soluble tetra-ethyl dicarboxy analogue DCTEIO (1b) that was a more effective antioxidant than the CTMIO parent [41] .
Hence here we focused on converting dicarboxy tetraethyl isoindoline nitroxides to fluorophore-containing nitroxides to generate probes that are responsive to specific cellular compartments and conditions. The ethyl groups in 5b and 8b should substantially decrease cellular reduction. Notably, the negative reduction potential of redox couples present within the mitochondria serve to rapidly generate the non-radical fluorescent hydroxylamines (6b and 9b). Consequently the probe is predominantly "switched off" and therefore has low fluorescence emissivity, except in mitochondria. ROS and oxidising species should be able to re-form the nitroxide and therefore the levels of fluorescence from within the mitochondria are expected be responsive to the redox potential of redox couples within this organelle.
Synthesis of tetraethyl nitroxide fluorescein and rhodamine analogues
The synthesis of the tetraethyl nitroxide fluorescein analogue (2b) was achieved via the condensation of two equivalents of resorcinol with the anhydride generated from a dicarboxyisoindoline nitroxide, in a manner analogous to our previous synthesis [11] of the tetramethyl analogue 2a (Scheme 1). The nitroxide anhydride is readily obtained by cyclisation of the dicarboxy nitroxide (1b or 1d) in acetic anhydride, and reaction of this with resorcinol gives a sulfonate ester intermediate (not isolated) that can be reacted with NaOH to produce the fluorescein 
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Free Radical Biology and Medicine 128 (2018) [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] in the dianion form [11] (Scheme 2) The ortho dicarboxy substitution in the ring of the starting materials (such as 1b), allows access to fluoresceins in good yield in a simple one pot procedure. Fluoresceins may also be converted to rhodamine derivatives via palladium-catalysed Buchwald-Hartwig amination to exchange the phenolic hydroxyl groups with secondary amines. This was achieved by first converting the -OH groups to triflates (in this case 4a and 4b) followed by Pd-catalysed amination with pyrrolidine to give the pyrrolidinorhodamine nitroxides as the chloride salt.
As the fluorescence response of fluorescein is pH dependent and can be bleached by the light sources used in microscopy, we focused on the rhodamine analogues. Product 5b was of most interest because the tetraethyl analogues possess enhanced stability towards bio-reduction. Furthermore, rhodamines are known to accumulate in mitochondria, driven by the membrane potential. The nitroxide 5b can be further derivatised to give the methoxyamine 7b as a positive control for fluorescence experiments with 5, as they should display similar localisation and transport as the pro-fluorescent nitroxide probes, but they are permanently fluorescent and unaffected by the redox environment.
Comparison of reduction rates of tetra-methyl vs tetra-ethyl probes by ascorbate
To assess the comparative rates of reduction for the fluorescein and rhodamine probes (2a, 2b or 5b) their reaction with ascorbate was monitored over time (Fig. 2) . The reaction of ascorbate with the tetraethyl analogues is significantly slower (~10-fold), as indicated for fluoresceins 2a and 2b, in Fig. 2 rhodamine 5b displayed no apparent reduction over this time period (data not shown). Thus, the reduction of tetraethylnitroxides by ascorbate is slow compared to the methyl analogues (2a vs 2b) and not detectable for the tetraethylnitroxide/rhodamine analogue 5b.
Reduction of fluorescein and rhodamine probes 2b and 8b by mitochondrial membranes
To determine whether biological systems could be more potent at reducing these nitroxides than ascorbate, we incubated them with isolated mitochondrial membranes (Fig. 3) . When the membranes were supplied with the respiratory substrate succinate, the conversion of the nitroxides 2b and 8b to the more fluorescent hydroxylamines could be observed (Fig. 3A and B) . Under these conditions, succinate will be oxidised by succinate dehydrogenase and thereby pass electrons on to the coenzyme Q pool and to all respiratory chain carriers between CoQ and oxygen, hence nearly all possible sites of reduction of nitroxides within the mitochondrial respiratory chain will be supplied with electrons and could in principle act as the site of reduction.
A lag period before the fluorescence increase occurred was evident and its duration was proportional to the amount of dissolved oxygen present in the closed cell, as the lag period could be shortened by bubbling with argon. Together, these data suggest that the rapid respiration of the mitochondrial membranes depleted the oxygen and enabled reduction of the nitroxide. This was supported by the fact that the lag period lengthened when the cell was stirred rapidly when open to the air to enhance diffusion of oxygen into the suspension. The role of dissolved oxygen in converting the fluorescent hydroxylamine 3b to the less fluorescent nitroxide 2b, was further confirmed by an experiment where respiration by the membranes was allowed to deplete the dissolved oxygen and then the fluorimeter cell was re-aerated by shaking with air for 10 s Fig. 3 shows the reversible fluorescence response generated in this experiment. To confirm that the reduction process required electrons supplied by succinate, we added malonate, a competitive inhibitor of succinate dehydrogenase, which prevented the reduction of the nitroxide.
When whole mitochondria were used instead of mitochondrial membranes, the fluorescence switch-on was much greater for the rhodamine based probe, which correlates to the greater uptake expected for a positively charged rhodamine 8b over the neutral/negatively charged fluorescein 2b (Fig. 4) .
The same reversible cycling behaviour could be demonstrated for the tetraethyl rhodamine nitroxides (see SI Figure SI3 ), although more
Fig. 2.
Comparative reduction rates by excess ascorbate of the fluorescein (tetra-methyl) nitroxide probe 2a compared to the tetra-ethyl analogue 2b. Blanks with no ascorbate addition are also displayed (lower light grey data points), showing no increase in fluorescence over this time, with the tetra-ethyl analogue 5b results being indistinguishable from the blank. A 0.5 µM concentration of fluorescein or rhodamine probes (2a, 2b or 5b) was prepared in 4 mL PBS and argon was bubbled through the solution to lower oxygen levels. Reduction was initiated by the addition of 375 µM ascorbate (> 750 M excess). Fluorescence intensity was monitored over time (600 min) and the relative reduction rates were determined based on the slope of the graph of percentage fluorescence intensity changes against time.
demanding redox conditions are required as expected from the limited degree of reduction arising from treatment with excess ascorbate.
These data are consistent with nitroxide reduction by mitochondrial reductive processes that are supplied with electrons by succinate and that the lipophilic cation character of the rhodamine-based probes enhances the uptake of this molecule into mitochondria.
Visualising the localisation of the rhodamine nitroxide 5b in mitochondria within cells
Simple co-localisation experiments demonstrate that the tetrethylrhodamine nitroxide 5b predominantly localises within the mitochondria. An overlaid image for cells treated with 5b and MitoTracker Green (Fig. 5C ) supports such mitochondrial localisation. There is evidence for a slightly broader distribution for 5b than for MitoTracker Green, as images also show some rhodamine fluorescence from within globular structures that were not evident with MitoTracker Green treatment. SoftWorx image analysis was used to determine a coefficient of correlation co-localisation plot (Fig. 5D) which shows how the two emissions (from 5b and MitoTracker Green) correlate on a pixel-by-pixel basis (where each spot represents a pixel). Based on these images, a co-localisation value of 0.7269 was obtained indicating that most of the 5b follows the same distribution as MitoTracker Green.
An overlaid image from cells treated with 5b compared to LysoTracker Blue treated cells (Fig. 5G) indicates some localisation of the rhodamine probe to lysosomes with the other globular structures, possibly endosomes. Notably, there is limited fluorescence arising from the cytoplasm. This fluorescence behaviour correlates with 5b only reaching detectable fluorescence levels on uptake into the mitochondria, where it is reduced to the more fluorescent hydroxylamine (6b). Some subsequent excretion of 6b would account for fluorescence arising from endosomes and lysosomes.
Cells treated with the rhodamine probe 5b were subsequently treated with either rotenone or antimycin, thereby interrupting the mitochondrial electron transport chain, blocking the supply of electrons to potential reducing sites and also giving rise to higher levels of oxidants. This would be expected to tilt the redox balance towards a more oxidising environment and thereby decrease the overall fluorescence generated. Decreased fluorescence would arise from diminished mitochondrial reduction of 5b and because some of the hydroxylamine 6b would be re-oxidised back to 5b. Flow cytometry was used to monitor cells treated with 5b, which confirmed that lower fluorescence arises in a dose responsive manner to mitochondrial inhibition (Fig. 6B) . The redox responsive probe MitoSox was used as a positive control (Fig. 6C) and demonstrated a dose dependent response to both rotenone and antimycin, reflecting enhanced oxidising conditions in the mitochondria arising from inhibition. The methoxyamine 7b was used as a negative control (Fig. 6D) and this non-redox active analogue showed no dose-dependent changes in fluorescence. Taken together, these results support the concept that the hydroxylamine/nitroxide ratio controls the probe brightness. Inhibitors that deliver conditions producing increased levels of ROS and stronger oxidation driven switch-on of MitoSOX, tilt the balance towards the nitroxide and lead to a decrease in the fluorescence response detected from cells treated with the rhodamine PFN probe 5b.
The mitochondrial membrane potential provides a driving force to accumulate positively charged species. The rhodamine nitroxide 5b will be taken up by the mitochondria as the free acid form (RCOOH) that exists in equilibrium with the conjugate base (Scheme 3). This will lead to greater uptake into the mitochondria due to the combined effect of the uptake of the weak acid driven by the pH gradient and the membrane potential on the fixed positive charge [43] However, the pKa of the carboxylic acid and the consequent significant proportion of the zwitterionic form of either 5b or 6b would slow the uptake of the compounds across the plasma membrane. To circumvent this, 5b was esterified to lock the compound as the permanently positively charged 8b and also to increase the hydrophobicicty, both of which enhance uptake into the cell and thus provide a stronger fluorescence response driven by mitochondrial action.
There was significantly increased uptake of the rhodamine nitroxide methyl ester 8b compared to 5b, enabling us to achieve mitochondrial labelling at much lower incubation concentrations (5 nM of 8b compared to using 1 μM of 5b). To further assess the relative uptake, we next studied the redox insensitive non-radical methoxyamine deriviatives (7b or 10b), which have the same fluorescence as the fully reduced probes, and which possess similar physicochemical properties and therefore reflect the fluorescence performance expected when the nitroxide (5b or 8b) is fully reduced to the non-radical hydroxylamine (6b or 9b). Fig. 7 shows that when cells are incubated with the rhodamine probe 5b using a lower concentration of probe (5 nM), there is negligible detectable fluorescence (Panel A). This was also the case for the methoxamine derivative (7b) at this concentration (Panel B). This indicates that, at this concentration, there is insufficient compound taken up into the mitochondria to be detectable under these conditions. However, this was not the case when 8b was used at the same concentration (5 nM), when there was readily detectable fluorescence within the mitochondria. Incubation with the fully fluorescent methoxyamine derivative (10b) (Panel D) at the same concentration shows the signal that would be expected if all of the nitroxide 8b was converted to non-radical hydroxylamine 9b.
A correlation plot for the rhodamine nitroxide methyl ester 8b and MitoTracker Green (Fig. 8) indicates an increased correlation (0.9217), likely due to the lower concentrations used, which correspond to less induction of excretion pathways.
One of the challenges of applying intensity-based sensors such as pro-fluorescent nitroxides is that emission intensity can be affected by other factors including probe concentration and laser intensity. Ideally the collection of the least ambiguous information requires the use of ratiometric sensing methods, for which spectral changes rather than intensity changes are recorded [44] . Ratiometric sensing is traditionally achieved by using probes that change colour in response to analytes, and to this end Förster resonance energy transfer (FRET)-based ratiometric sensors for cellular redox environment have been developed [45] . However, in theory, any parameter that changes with location can be measured through image mapping methodology that allows the determination of relative ratios. PFNs, with their short fluorescence lifetimes compared to their fluorescent non-radical counterparts, therefore offer an opportunity for lifetime-based ratiometric imaging using fluorescence lifetime imaging microscopy (FLIM). We demonstrate here, for the first time, the power of this technique using 5b.
DLD-1 colorectal adenocarcinoma cells were treated with 5b and visualised by confocal microscopy. Cells were then treated with the oxidant hydrogen peroxide or with the inhibitors rotenone and antimycin to disrupt mitochondrial redox balance. By confocal imaging, it was possible to observe a decrease in fluorescence intensity under oxidising conditions, consistent with more probe in the oxidised, profluorescent form (Fig. 9A) . Fluorescence lifetime imaging was achieved using two-photon excitation at 820 nm, and all images could be fit to biexponential decay with two fluorescence lifetimes, of 1.3 ns and 2.9 ns, corresponding to the pro-fluorescent radical and fluorescent nonradical respectively. Average lifetimes decreased after treatment with oxidants ( Fig. 9C-F) , consistent with greater proportions of the profluorescent nitroxide radical in these conditions. These average lifetime changes corresponded to changes in the contribution of shorter and longer lifetimes (Fig. 9B) : such values are independent of the concentration of the probe, and therefore can be considered to be a ratiometric output.
Discussion
Imaging studies for both fluorescein-and rhodamine-based probes over a range of concentrations indicate broad distribution throughout Scheme 3. Small equilibrium concentrations of 5b present in the RCOOH form (pro-fluorescent, dark), would be driven into the mitochondria by the membrane potential due to the overall positive charge on the molecule. Outside the mitochondria the reduction of the tetraethyl nitroxide probe is slow. Inside the mitochondria the probe would be rapidly reduced and loss of the free radical restores the usual fluorescence emission from the rhodamine fluorophore. the cell, as well as with higher accumulations in specific cellular compartments. At lower concentration treatments and influenced by exposure times, the fluoresceins are detectable mainly in the membranes and excretory bodies [11] . The fate of the fluorescein probe 2b taken up by the cell is likely to involve some reduction in the cytosol, but this would be slow compared to the methyl analogue 2a. It is also likely to involve entry into, and more rapid reduction within, the mitochondria followed by excretion of the resultant hydroxylamine and some amount of re-oxidation by oxygen and other oxidants. The fluorescein 2b displays highly reversible redox sensitivity in fluorimeter-based studies and flow-cytometry experiments, but is less suitable for confocal microscopy, where photo-bleaching may become an issue.
In contrast, the rhodamines 5b and 8b are more robust for confocal imaging and also demonstrate accumulation largely within the mitochondria. There is a greater degree of "switch-on" of fluorescence within these organelles, as indicated by the fluorescence lifetime experiments (Fig. 9) . The esterification of 5b to give 8b increases mitochondrial accumulation, such that a detectable fluorescence response can be obtained by cell incubations at concentrations as low as 5 nM, minimising impact on cell and mitochondrial membrane integrity. The reversibility of probe fluorescence is demonstrated by the increase and decrease of fluorescence emission on exposure to mitochondrial membranes and isolated mitochondria followed by exposure to oxygen. In cell imaging studies, the methyl ester probe 8b shows a significant fluorescence response to antimycin and rotenone treatment, demonstrating that the PFN probes 8b holds potential as a tool to monitor mitochondrial redox status.
Conclusion
We have shown that dicarboxy nitroxides can be used to generate a new class of redox-responsive probes. These probes provide a real-time and reversible response that enables the monitoring of the mitochondrial redox state within cells and holds promise for the assessment of mitochondrial redox status in cells under a range of conditions. 
